Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-13 22:15:16 EDT

Explore

PostsPeople
LatestRanked
Load more
@thewellthcounselor.bsky.socialSep 21, 2026, 11:21 PM

Enjoy this clip from #TheGlenAlexShow🎙️Glen's guest #MikeBovarnick shares his #ProstateCancer and #TheProstateEducationProject to help men and their families🙏🏽 Catch the full episode on YouTube Channel @LivingInTotalHealthGlenAlex #MensHealth

@artera.aiSep 21, 2026, 8:01 PM

Heading to #ASTRO26?

The Artera team will be onsite and looking forward to connecting with the radiation oncology community and discussing the role of AI-powered biomarkers in #ProstateCancer care.

#ArteraOnTheGo

Photo, no description
@ancan501c3.bsky.socialSep 21, 2026, 9:45 AM

TODAY if you're dealing with #prostatecancer, our meeting us at 6pm ET TODAY
September meetings will be held on:

Monday Sep 21, 8pm ET

Our meeting will end promptly to allow our Care Partners to have the room

https://www.gotomeet.me/AnswerCancer

#cancersupport #brca

Photo, no description
@fierymark.bsky.socialSep 21, 2026, 8:34 AM

Given that it’s World Gratitude Day, I wish to thank being in a country where, being of a certain age now, I get to experience a handsome GP inserting their finger in my rectum for free just cos I asked them nicely.
You can do this too.
It’s quick, simple and could be a lifesaver.
#ProstateCancer

@healthcare-europe.bsky.socialSep 21, 2026, 6:30 AM

Research co-led by 🇪🇸 @cniostopcancer.bsky.social may explain why many men live with #prostatecancer for decades while for others it turns lethal: The work identifies what causes DNA damage in most of the cancers. http://dlvr.it/TVZKZ2

Photo, no description
@michaelkearsley.bsky.socialSep 20, 2026, 12:05 PM

A new report on #23andme about a #prostatecancer related gene, apparently I don't have it, though it was only testing for one variant, but that's good.

@tragicmammal.bsky.socialSep 19, 2026, 2:52 PM

Support the Lakes Prostate Cancer (LPC) Fund and help make a difference in the lives of those they serve. Every donation, large or small, helps strengthen their mission and community.

Donate: lpcfund.org

#LPCFund #Donate #GiveBack #CommunitySupport #Brainerd #Minnesota #ProstateCancer #Men'sHealth

@stemcellsciencenews.comSep 18, 2026, 10:15 PM

🧬 Exciting @nature.com article delineates the etiologies and mutational processes that drive the genomic and clinical heterogeneity of #ProstateCancer.

👓 Read how they investigated the #genomes of 959 donors: https://go.nature.com/4he7snZ

Photo, no description
@gmj-georgia.bsky.socialSep 18, 2026, 3:26 PM

🔬 PROTEUS trial in Nature Medicine (June 2026) shows perioperative apalutamide + androgen-deprivation therapy offer new hope f… #Androgendeprivationtherapy #Apalutamide #Perioperativeoncology #Prostatecancer #PROTEUStrial #Androgendeprivationtherapy #Apalutamide #Perioperativeoncology #Prostate…

@danafarbernews.bsky.socialSep 18, 2026, 2:30 PM

When to get screened for #ProstateCancer: @danafarber.bsky.social’s Dr. Mark Pomerantz talked with @boston25news.com. September is #ProstateCancerAwareness Month.

➡️bit.ly/3TtWXF4

@jamaoncology.comSep 18, 2026, 2:00 PM

Prebiopsy #MRI use before #ProstateCancer biopsy increased in the US from 2017 to 2026, reaching 64.1% of biopsy-naive patients, but uptake remained incomplete. ja.ma/4gPW16U

Two line graphs show prebiopsy MRI use. Graph A (2017-2026) shows an increasing trend for 'biopsy naive' and 'prior negative biopsy result' patients, with the latter consistently higher. Graph B (2024-2026) details these percentages across RUCA, Race, Age, & PSA subgroups.
@vcclibrary.bsky.socialSep 18, 2026, 9:40 AM

Patient-clinician symptom agreement before and after radiotherapy for #ProstateCancer: results from the randomized HYPO-RT-PC study. www.thegreenjournal.com/article/S016...

@thecancersurvivorsclub.comSep 18, 2026, 8:28 AM

Prostate cancer treatment is becoming increasingly personalized. Genetic testing, targeted treatments, radioligand therapy and emerging immunotherapies are helping doctors match treatment more closely to individual cancers.

www.jnj.com/health-and-w...

#ProstateCancer #CancerTreatment #TCSC

@dximaging-mjh.bsky.socialSep 18, 2026, 12:06 AM

Prostate #MRI Study Links Lower ACD Values on DWI to Higher Long-Term Risk of Distant Metastases
www.diagnosticimaging.com/view/prostat...
#radiology #RadRes #ProstateCancer

Photo, no description
@fredhutchbiostat.bsky.socialSep 17, 2026, 10:15 PM

🎉Congratulations to Ruth Etzioni & the CISNET Prostate Working Group on renewed NIH funding. The team will continue developing models to inform prostate cancer screening, staging, and treatment decisions, updating their frameworks to reflect current clinical practice. #prostatecancer

@sdvoice.infoSep 17, 2026, 8:15 PM

💙 Black men are nearly 70% more likely to be diagnosed with the disease and early detection can play an important role in treatment. Learn more about the risks and the importance of talking with your doctor. 🔗 sdvoice.info/prostate-can...

#ProstateCancer #BlackMen #MensHealth #VoiceAndViewpoint

Photo, no description
@medi-cal.bsky.socialSep 17, 2026, 3:24 PM

🩺 Medi-Cal Specialty Care helps with testing and treatment for prostate cancer.

Book your checkup at my.medi-cal.ca.gov

#MediCal #ProstateCancer #HealthyCA #SpecialtyCare

Hands holding a blue ribbon with a black mustache cutout. The text reads: "Medi-Cal. 1 in 8 men will face prostate cancer. Talk to your doctor to find out when to schedule your appointment." The background is light blue with decorative swirls.
@oncoalert.bsky.socialSep 17, 2026, 11:40 AM

🚨 Day One at #GUARDSymposium2026 | OncoAlert Coverage
🧬 Can machine learning help us understand metastatic risk in prostate cancer?

Sonia Macía 🇪🇸 presents MET-score—an explainable machine-learning approach using transcriptomic data to model metastatic risk in #ProstateCancer

Photo, no descriptionPhoto, no descriptionPhoto, no descriptionPhoto, no description
@cancers-mdpi.bsky.socialSep 17, 2026, 10:11 AM

🎯Editor's Choice Paper
#Immunotherapeutic Strategies for #ProstateCancer: A Comprehensive Review
✍️Ana K. Flores-Islas, Cecilia Rico-Fuentes et al.
Find out more🖇️ www.mdpi.com/2072-6694/18...
#PCa #ICIs #mCRPC

Figure 1. PCa tumor immune microenvironment (TIME). An immunosuppressive environment and Immunological ignorance characterize TIME in PCa tumors; some of the most relevant immune cells are effector Treg cells (eTreg), CD8+ T cells, M2 tumor-associated macrophages (TAMs), CD4+ T-cells, and myeloid-derived suppressor cells (MDSCs). Tumor-associated antigens and tumor-specific antigens can be used as diagnostic, prognostic/treatment, or research tools in PCa. PSA: Prostate-specific antigen; PSMA: Prostate-specific membrane antigen; PAP: Prostate acid phosphatase; PSCA: Prostate stem cell antigen; STEAP: Six-transmembrane epithelial antigens of the prostate; PCA3: Prostate cancer antigen 3.
@artera.aiSep 16, 2026, 9:01 PM

We’re looking forward to connecting with the urology community at @therapy_focal and the Southern Society of Urologic Surgeons Annual Meeting this September.

If you're attending, be sure to connect with the Artera team. 👇

#ProstateCancer #Urology #ArteraOnTheGo

Photo, no descriptionPhoto, no description